hormones researchTongkat Ali and Testosterone: What Seven Controlled Trials Actually Show
Tongkat Ali raised testosterone to normal in 90.8% of deficient men in a 2012 RCT. This is what the clinical evidence actually demonstrates — and where it doesn't.
Before researchers ran a clinical trial, Eurycoma longifolia had been used for centuries across Malaysia, Indonesia, and Thailand as a tonic for male vitality. In 2012, a randomized trial put that tradition to a controlled test. Seventy-six men with confirmed late-onset hypogonadism took 200 mg of a standardized Tongkat Ali extract daily for one month. Before supplementation, 35.5% had normal testosterone levels. After one month: 90.8%.
That single figure is worth understanding precisely — both what it means and what it does not.
Eurycoma longifolia is a slender tree native to the lowland rainforests of Malaysia, Indonesia, Thailand, and Vietnam. Its root extract has been used in traditional Malay medicine as a male tonic for centuries — marketed there under the name "Tongkat Ali" (literally: "Ali's walking stick") and as "pasak bumi" in Indonesia. What separates it from most traditional herb-to-supplement translations is the volume of controlled clinical evidence that has accumulated, and the specificity of the proposed mechanism.
What the Tambi Trial Actually Measured
The 2012 Tambi et al. study, published in Andrologia, enrolled men who were already deficient or borderline-deficient. These were not young athletes with normal testosterone looking for a marginal edge. They were men whose HPG axis was underperforming — for whom there was biological room to recover.
This distinction matters enormously when evaluating Tongkat Ali's reputation as a "testosterone booster." The 90.8% figure means the majority of these men moved from below-normal into the normal reference range. It does not mean they doubled their testosterone or exceeded what their biology would naturally produce. It means the suppression or underperformance was corrected.
The extract used was Physta® — a standardized, water-soluble, hot-water extraction of the root, characterized by its specific quassinoid profile. This matters because it is not interchangeable with uncharacterized "tongkat ali root powder" sold in generic supplements.
A 2022 systematic review and meta-analysis that pooled five RCTs found a significant increase in serum total testosterone (SMD = 1.352, 95% CI 0.565–2.138, p = 0.001), confirmed in both healthy volunteers and hypogonadal subgroups. This is a medium-large effect size by convention — not trivial, but not equivalent to pharmaceutical testosterone either.
Four Mechanisms Behind the Effect
Most supplement marketing stops at "tongkat ali increases testosterone." The mechanism is considerably more specific, which is why the effect is population-dependent and extract-dependent.
Mechanism 1: Aromatase inhibition
The primary active compound, eurycomanone — a quassinoid found exclusively in the Eurycoma longifolia root — inhibits aromatase (CYP19A1), the enzyme responsible for converting testosterone into estradiol. In men with elevated estrogen-to-testosterone ratios, this single mechanism alone would tip the balance toward free testosterone. A 2013 in vitro study in Phytomedicine (Kang et al.) demonstrated that eurycomanone's docking orientation to aromatase closely resembled that of formestane, a pharmaceutical aromatase inhibitor, and produced significant reductions in estrogen synthesis while sparing testosterone.
This is not the same as a pharmaceutical aromatase inhibitor like anastrozole — the effect size is smaller and the mechanism less targeted — but it is a genuine, measurable effect at the cellular level.
Mechanism 2: HPG axis upregulation
Tongkat Ali also stimulates the hypothalamic-pituitary-gonadal axis upstream. LH (luteinizing hormone) and FSH (follicle-stimulating hormone) levels rise with supplementation, increasing the signal to Leydig cells in the testes to synthesize more testosterone. This is the same axis that TRT suppresses — exogenous testosterone shuts down LH production via negative feedback. Tongkat Ali, by contrast, amplifies rather than replaces the signal.
The HPG axis works through a pulsatile cascade: GnRH from the hypothalamus → LH and FSH pulses from the anterior pituitary → testosterone and sperm production in the testes → negative feedback loop that regulates the whole system. Tongkat Ali appears to modulate the sensitivity of this cascade — potentially by reducing estrogen-mediated negative feedback (via aromatase inhibition) and by direct effects on hypothalamic GnRH release. The result is a higher set point for LH pulsatility, which means the Leydig cells receive a stronger signal to produce testosterone throughout the day. The 2021 Chan et al. study in young males observed increases in LH alongside total and free testosterone, supporting this upstream mechanism rather than a direct peripheral effect on steroidogenesis alone.
Mechanism 3: Cortisol pathway interference
This is the mechanism most commonly overlooked, and the one most relevant to the target audience of PrimalPrime — men under occupational, physical, or psychological load.
Cortisol and testosterone are both synthesized from the same precursor: pregnenolone. When the hypothalamic-pituitary-adrenal (HPA) axis is chronically activated under stress, cortisol synthesis is prioritized, reducing the substrate available for testosterone production. This is why chronic stress reliably suppresses testosterone — it is not a metaphor, it is a competition at the biochemical level.
The Talbott et al. 2013 RCT (63 moderately stressed adults, 200 mg/day for 4 weeks) measured this directly: salivary cortisol fell 16% versus placebo while testosterone rose 37%. Both effects were statistically significant. The interpretation is that Tongkat Ali's stress-moderating effect and its testosterone effect may share a common mechanism — reduce HPA overactivation, and the pregnenolone that was fueling cortisol synthesis becomes available for testosterone production downstream.
For executives, athletes in competition preparation, or men in periods of high professional load, this may be the most clinically relevant pathway.
Mechanism 4: SHBG displacement and free testosterone
Sex hormone-binding globulin (SHBG) binds testosterone in circulation, rendering it biologically inactive. Only free testosterone (roughly 2–3% of total) enters cells and exerts androgenic effects. Eurypeptides — the water-soluble protein fractions in standardized extracts — appear to release bound testosterone from SHBG, increasing the free fraction without necessarily changing total testosterone. This explains why some trials report larger increases in free testosterone than total testosterone. A 2021 multicentre study using Physta® showed free testosterone increasing by 34% while total testosterone increased by 15%.
The Stress-Testosterone Bridge
The 2013 Talbott stress trial is underappreciated in the Tongkat Ali literature. It enrolled participants who were "moderately stressed" as defined by validated psychological instruments — not clinically depressed, not pathologically anxious, but carrying the kind of chronic low-grade load that characterizes the male executive or high-performance professional demographic.
At baseline, this population showed lower testosterone and higher cortisol compared to unstressed reference populations. Four weeks of 200 mg/day significantly moved both markers. The relevance of this finding is not that Tongkat Ali is a stress supplement — it is that the mechanism by which it improves testosterone is precisely the mechanism that chronic stress disrupts.
A man whose testosterone is suppressed primarily because his HPA axis is chronically overactive — elevated cortisol competing for pregnenolone — would logically respond better to Tongkat Ali than a man whose testosterone is suppressed for other reasons (primary hypogonadism, SHBG elevation, age-related Leydig cell decline). The research does not yet segment responders by causal mechanism, but the biology suggests this distinction is real.
This also explains a common clinical observation: men who begin Tongkat Ali after cleaning up sleep and stress report stronger effects than those who start it while still chronically sleep-deprived or overworked. The supplement amplifies a functional HPA-HPG system; it does not rescue a systemically dysregulated one. When the underlying cortisol burden is removed — through adequate sleep, managed workload, or reduced overtraining — Tongkat Ali can then modulate the now-responsive axis more effectively. In practice, this means addressing the lifestyle floor before expecting meaningful pharmacological gain from the supplement ceiling.
Where the Evidence Gets Honest
The clinical picture is more nuanced than Tongkat Ali's marketing suggests, and understanding the nuances determines whether you're likely to respond.
Population dependency is real. The most dramatic effects — the 90.8% normalization in the Tambi trial — require baseline deficiency. The 2021 Chan et al. trial in young males showed increases of 15% in total testosterone at 600 mg/day. Significant, but not the dramatic response seen in low-T populations. Well-optimized young men with testosterone in the high-normal range should expect modest effects.
Short durations produce inconsistent results. A 2023 study in rugby players (PMC10286614) found no significant effects on hormones or performance after 7 days of supplementation before eccentric exercise. Mechanistically, this is not surprising — the HPG axis and cortisol pathway respond over weeks, not days. Single-week protocols tell you almost nothing about Tongkat Ali's hormonal effects.
The male sexual function data is supportive but complex. The 6-month ADAM trial (Ismail et al., 2021) found improvements in erectile function alongside testosterone gains, but the intervention combined Tongkat Ali with concurrent resistance exercise — making it difficult to attribute specific magnitude of effect to the supplement alone. Erectile function responds to multiple overlapping pathways, including vascular and neurological factors beyond testosterone.
Effect sizes in healthy men are real but modest. The 2022 meta-analysis found a significant effect across all men, including healthy volunteers. But the confidence interval is wide (0.565–2.138 SMD), which reflects genuine heterogeneity between populations. No trial has shown Tongkat Ali producing supraphysiological testosterone in men who already have normal levels.
The label 'tongkat ali' on a supplement tells you almost nothing about what's inside. The standardized extracts used in clinical trials and an uncharacterized root powder share a plant name and almost nothing else.
Athletic Performance: A More Mixed Picture
The testosterone evidence is stronger than the athletic performance evidence, and conflating the two is a common error.
A pilot study in active adults using 100 mg/day of a standardized extract for 5 weeks found increased muscle strength and fat-free mass. A 400 mg/day trial in aging adults showed improved grip strength. These are supportive findings but are pilot-scale — small samples, limited controls.
The 2023 rugby player study (Phatsorn Pikulkaew et al., PMC10286614) provides the clearest negative data: 7 days of Tongkat Ali supplementation before an eccentric leg press protocol showed no significant effect on hormones, performance, or muscle damage markers. This is a well-controlled null result. Seven days is simply not long enough to modulate the HPG axis in a meaningful way.
For athletic populations, the argument for Tongkat Ali rests on two different pillars. First: for masters athletes (40+) who have lower-normal testosterone, the hormonal optimization evidence is the strongest rationale — normalize testosterone, and performance follows as a downstream consequence. Second: for athletes in high training blocks with chronically elevated cortisol and suppressed testosterone, the stress-cortisol pathway provides a mechanistic rationale that the short-duration trials would not capture.
What the data does not support is using Tongkat Ali as an acute performance enhancer or pre-competition ergogenic aid. It is an endocrine regulator that requires weeks of consistent use to produce measurable hormonal shifts.
Tongkat Ali vs. Ashwagandha: Mechanistic Differences
Both herbs are frequently marketed for testosterone support, and comparing them helps clarify when each makes more sense.
Ashwagandha (specifically KSM-66) reduces cortisol primarily through the HPA axis — its withaferin A and withanolide content acts on cortisol regulation via the stress response cascade. Its testosterone effect is secondary and appears primarily in men with elevated stress hormones. The Wankhede et al. 2015 RCT in resistance-trained men showed significant testosterone increases alongside cortisol reductions — the mechanism is similar to the Talbott Tongkat Ali trial in that cortisol suppression may be the primary driver.
Tongkat Ali operates through more direct androgenic pathways in addition to cortisol suppression — the aromatase inhibition and direct LH-driven steroidogenesis effects are not shared by ashwagandha. This makes Tongkat Ali a more targeted androgenic intervention, while ashwagandha functions more broadly as an adaptogen with testosterone effects as a downstream benefit.
In practice, they are not competitive but potentially complementary — one reducing the stress-mediated suppression of testosterone (ashwagandha's primary route) while the other simultaneously increases the efficiency of testosterone synthesis (Tongkat Ali's aromatase and HPG route). Whether stacking them produces additive effects has not been studied in controlled trials.
Standardization: The Most Important Variable No One Discusses
The Tongkat Ali market is not regulated in a way that ensures product quality. This matters more here than for most supplements, because the quassinoid content of raw plant material varies significantly by geography, soil, harvest season, extraction method, and root age (older roots contain higher eurycomanone concentrations).
Clinical trials have used three main standardized preparations:
- Physta® (Hot-water aqueous root extract, standardized by Biotropics Malaysia) — used in the Tambi 2012 trial, the stress hormones trial (Talbott 2013), and the Physta multicentre study
- LJ100® (Patented extract developed through MIT research, standardized to 22% eurypeptides, 40% glycosaponins, 1.5% eurycomanone) — used in Henkel et al. 2014
- Longjax® — a licensed extract with its own standardization parameters
A capsule containing "tongkat ali root powder" at no specified standardization is not equivalent to any of these and has not been studied in controlled trials. The difference between an uncharacterized root powder and a standardized extract is not a minor quality difference — it is the difference between a study drug and a handful of ground root of unknown chemical composition.
This is not a minor technicality. It is the single largest variable in whether you will see any effect at all.
Protocol: How to Use Tongkat Ali
Who is likely to respond:
- Men with total testosterone in the low-normal range (300–500 ng/dL) or confirmed borderline hypogonadism
- Men under sustained occupational or physical stress with elevated cortisol and suppressed testosterone
- Men over 45 with age-related testosterone decline but intact HPG axis function
- Men using it as part of a broader lifestyle optimization stack alongside sleep, resistance training, and managed stress load
Who is unlikely to see significant effects:
- Men with testosterone already in the upper third of the normal range
- Men with primary hypogonadism (damaged testes or absent Leydig cell function) — Tongkat Ali stimulates the HPG axis but cannot compensate for end-organ failure
- Men expecting rapid results — the mechanism requires weeks of consistent use
Practical protocol:
- Use a standardized extract only: Physta®, LJ100®, or Longjax®. Verify standardization on the label. If the label does not specify eurypeptide or quassinoid content, do not use it.
- Dose: 200 mg/day is the best-studied dose. Take with or without food; timing does not appear to matter significantly in trials.
- Duration: Commit to a minimum of 8 weeks before assessing response. Short-term use will not produce meaningful hormonal data.
- Baseline bloodwork: Get a baseline total testosterone and free testosterone before starting. Repeat at 8–12 weeks. Without baseline data, you cannot assess response.
- Stack rationally: Tongkat Ali pairs well with sleep optimization (the primary testosterone lever), stress load reduction (synergistic via cortisol pathway), and resistance training. It is not a replacement for any of these — it is an amplifier of an already-functional system.
- Cycling: No evidence supports mandatory cycling protocols, but periodic breaks (8 weeks on, 2–4 weeks off) may help maintain HPG axis sensitivity. This remains speculative — the 6-month ADAM trial used continuous supplementation without evidence of receptor desensitization.
What it cannot do:
It cannot restore testosterone in the presence of untreated sleep deprivation, unmanaged chronic stress, obesity (adipose tissue is the primary aromatase reservoir), or nutritional deficiency. If your cortisol is chronically elevated because you sleep 5 hours a night, no amount of Tongkat Ali will significantly normalize testosterone — address the upstream driver first.
Tongkat Ali is evidence-supported for a specific population, via a specific mechanism, using specific standardized extracts. That is a narrower claim than its marketing suggests, and a stronger claim than most "natural testosterone boosters" deserve. The man who responds best to this intervention is not the 25-year-old athlete with peak testosterone — it is the 40-year-old executive with borderline-low testosterone, elevated cortisol from chronic occupational load, and intact HPG axis function. For that man, the evidence is genuinely compelling. Understanding this distinction is what separates rational supplementation from wishful thinking.